Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study.

Following the rollout of a booster campaign to promote immunity against COVID-19 in China, this study aimed to assess booster hesitancy among adults who were fully vaccinated with primary doses across Zhejiang Province. Firstly, the modified 5C scale developed by a German research team was assessed for reliability and validity via a pre-survey in Zhejiang Province. Then, a 30-item questionnaire was established to conduct online and offline surveys during 10 November to 15 December 2021. Demographic characteristics and information on previous vaccination experience, vaccine type of primary doses, attitudes towards booster doses and awareness of SARS-CoV-2 infection were collected. tests, pairwise comparison and multivariate logistic regression were performed in data analysis. In total, 4039 valid questionnaires were analyzed, with booster hesitancy of 14.81%. Dissatisfaction with previous vaccination experience of primary doses (ORs = 1.7718.025), less confidence in COVID-19 vaccines (OR = 3.511, 95%CI: 2.8744.310), younger age compared to the elderly aged 51-60 years old (2.382, 1.2744.545), lower education level (ORs = 1.7072.100), weaker awareness of social responsibility of prevention and control of COVID-19 (1.587, 1.3531.859), inconvenience of booster vaccination (1.539, 1.3021.821), complacency regarding vaccine efficacy as well as self-health status (1.224, 1.0561.415) and excessive trade-offs before vaccination (1.184, 1.0051.398) were positively associated with booster hesitancy. Therefore, intelligent means should be strengthened to optimize vaccination services. More influential experts and other significant figures should be supported to promote timely evidence-based information via various media platforms to reduce public hesitancy and increase booster uptake.